NASDAQ:DRTSW Alpha Tau Medical (DRTSW) Stock Price, News & Analysis → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free DRTSW Stock Alerts $0.21 +0.02 (+10.54%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.20▼$0.2150-Day Range$0.19▼$0.2852-Week Range$0.14▼$0.45Volume3,316 shsAverage Volume8,265 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Alpha Tau Medical alerts: Email Address Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! About Alpha Tau Medical Stock (NASDAQ:DRTSW)Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.Read More DRTSW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DRTSW Stock News HeadlinesApril 19, 2024 | americanbankingnews.comAlpha Tau Medical (NASDAQ:DRTSW) Trading 10.7% Higher April 17, 2024 | msn.comAlpha Tau Medical (DRTS) Price Target Decreased by 11.90% to 9.44April 27, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… March 9, 2024 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateMarch 8, 2024 | investorplace.comDRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023February 23, 2024 | finance.yahoo.comAlpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth PlansJanuary 22, 2024 | msn.comIs Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year?January 13, 2024 | finance.yahoo.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) most popular amongst retail investors who own 58%, insiders hold 22%April 27, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… December 29, 2023 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS) Dividends: History, Yield and DatesDecember 15, 2023 | markets.businessinsider.comExpert Ratings for Alpha Tau MedicalNovember 29, 2023 | finance.yahoo.comAlpha Tau to Participate in Sidoti Small-Cap ConferenceNovember 22, 2023 | msn.comDown -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)November 20, 2023 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 19, 2023 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS), Analyst Ratings, Price Targets, PredictionsNovember 16, 2023 | finance.yahoo.comAlpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 1, 2023 | finance.yahoo.comAlpha Tau to Participate in November Investor ConferencesOctober 24, 2023 | finance.yahoo.comFormer U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardOctober 24, 2023 | finance.yahoo.comFormer U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardSeptember 14, 2023 | finance.yahoo.comAlpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterAugust 29, 2023 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 28, 2023 | seekingalpha.comAlpha Tau Medical GAAP EPS of -$0.24, revenue of $12.26MAugust 18, 2023 | seekingalpha.comAlpha Tau gains on data for radiation therapyAugust 18, 2023 | benzinga.comThinking about buying stock in Alpha Tau Medical, IONQ, Novo Integrated Sciences, Vale SA, or Rivian Automotive?August 6, 2023 | finance.yahoo.comInsiders own 24% of Alpha Tau Medical Ltd. (NASDAQ:DRTS) shares but individual investors control 54% of the companyAugust 5, 2023 | fool.comAlpha Tau Medical (NASDAQ: DRTS)June 29, 2023 | finance.yahoo.comDRTS - Alpha Tau Medical Ltd.See More Headlines Receive DRTSW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:DRTSW CUSIPN/A CIK1871321 Webwww.alphatau.com Phone972 3 577 4115FaxN/AEmployees121Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Uzi Sofer (Age 54)CEO & Chairman Comp: $630kMr. Raphi Levy (Age 39)Chief Financial Officer Comp: $424kMr. Amnon Gat (Age 49)Chief Operations Officer Comp: $340kMr. Peter M. Melnyk (Age 62)Chief Commercial Officer Comp: $376kDr. Robert B. Den M.D. (Age 45)Chief Medical Officer & Member of Scientific Advisory Board Comp: $401kMr. Ronen Segal (Age 51)Chief Technology Officer Comp: $380kProf. Yona Keisari (Age 77)Chief Scientific Officer & Member of Scientific Advisory board Ms. Rebecca BeckerVice President of legalProf. Itzhak Kelson (Age 84)Chief Physics Officer & Member of Scientific Advisory Board Ms. Yael Zeiger (Age 41)Corporate Controller More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWBioCardiaNASDAQ:BCDAWView All Competitors DRTSW Stock Analysis - Frequently Asked Questions How have DRTSW shares performed in 2024? Alpha Tau Medical's stock was trading at $0.1926 at the start of the year. Since then, DRTSW shares have increased by 8.9% and is now trading at $0.2098. View the best growth stocks for 2024 here. Are investors shorting Alpha Tau Medical? Alpha Tau Medical saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 1,600 shares, a decrease of 36.0% from the March 31st total of 2,500 shares. Based on an average daily volume of 5,900 shares, the short-interest ratio is presently 0.3 days. View Alpha Tau Medical's Short Interest. How do I buy shares of Alpha Tau Medical? Shares of DRTSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DRTSW) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
